1. (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151–1210. https://doi.org/10.1016/S0140-6736(17)32152-9
2. Fitzmaurice C, Global Burden of Disease Cancer Collaboration (2018) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study. JCO 36:1568–1568. https://doi.org/10.1200/JCO.2018.36.15_suppl.1568
3. Ghavimi S, Apfel T, Azimi H, et al (2020) Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options. Journal of Clinical and Translational Hepatology 8:168–176. https://doi.org/10.14218/JCTH.2020.00001
4. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. Journal of Hepatology 38:136–149. https://doi.org/10.1016/S0168-8278(02)00432-4
5. Llovet JM, Montal R, Villanueva A (2019) Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival. Journal of Hepatology 70:1262–1277. https://doi.org/10.1016/j.jhep.2019.01.028
6. Llovet JM, Hilgard P, de Oliveira AC, et al (2008) Sorafenib in Advanced Hepatocellular Carcinoma. n engl j med 13
7. Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, et al (2017) The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol 3:1683. https://doi.org/10.1001/jamaoncol.2017.3055
8. Garaycoechea JI, Crossan GP, Langevin F, et al (2018) Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature 553:171–177. https://doi.org/10.1038/nature25154
9. Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149–156. https://doi.org/10.1016/S1470-2045(06)70577-0
10. Seitz HK, Bataller R, Cortez-Pinto H, et al (2018) Alcoholic liver disease. Nat Rev Dis Primers 4:16. https://doi.org/10.1038/s41572-018-0014-7
11. Stickel F, Datz C, Hampe J, Bataller R (2017) Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver 11:173–188. https://doi.org/10.5009/gnl16477
12. Hye-Kyung Na, Ja Lee (2017) Molecular Basis of Alcohol-Related Gastric and Colon Cancer. IJMS 18:1116. https://doi.org/10.3390/ijms18061116
13. Orywal K, Szmitkowski M (2017) Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms. Clin Exp Med 17:131–139. https://doi.org/10.1007/s10238-016-0408-3
14. Ganne-Carrié N, Nahon P (2019) Hepatocellular carcinoma in the setting of alcohol-related liver disease. Journal of Hepatology 70:284–293. https://doi.org/10.1016/j.jhep.2018.10.008
15. Zhang C, Huang S, Zhuang H, et al (2020) YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene 39:4507–4518. https://doi.org/10.1038/s41388-020-1303-7
16. Castelli G, Pelosi E, Testa U (2017) Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. 36
17. Suetsugu A, Nagaki M, Aoki H, et al (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochemical and Biophysical Research Communications 351:820–824. https://doi.org/10.1016/j.bbrc.2006.10.128
18. Mima K, Okabe H, Ishimoto T, et al CD44s Regulates the TGF-b–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma. Cancer Research 11
19. Ma X-L, Shen M-N, Hu B, et al (2019) CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. J Hematol Oncol 12:37. https://doi.org/10.1186/s13045-019-0724-7
20. Ambade A, Satishchandran A, Szabo G (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep 6:21340. https://doi.org/10.1038/srep21340
21. Xu M, Luo J (2017) Alcohol and Cancer Stem Cells. Cancers 9:158. https://doi.org/10.3390/cancers9110158
22. Zheng K, Yu J, Chen Z, et al (2019) Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-β/RUNX3/Snail axis by inducing TGF-β1 upregulation and RUNX3 cytoplasmic mislocalization. EBioMedicine 50:224–237. https://doi.org/10.1016/j.ebiom.2019.11.011
23. Xu M, Wang S, Qi Y, et al (2016) Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells: ROLE OF MCP-1 IN ALCOHOL-INDUCED AGGRESSIVENESS. Mol Carcinog 55:1002–1011. https://doi.org/10.1002/mc.22343
24. Xu M, Wang S, Ren Z, et al (2016) Chronic ethanol exposure enhances the aggressiveness of breast cancer: the role of p38γ. Oncotarget 7:3489–3505. https://doi.org/10.18632/oncotarget.6508
25. Xu M, Ren Z, Wang X, et al (2016) ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis. Mol Cancer 15:. https://doi.org/10.1186/s12943-016-0532-4
26. Biswas A, Senthilkumar SR, Said HM (2012) Effect of chronic alcohol exposure on folate uptake by liver mitochondria. American Journal of Physiology-Cell Physiology 302:C203–C209. https://doi.org/10.1152/ajpcell.00283.2011
27. Pochareddy S, Edenberg HJ (2012) Chronic Alcohol Exposure Alters Gene Expression in HepG2 Cells: ALCOHOL ALTERS EXPRESSION OF MANY GENES. Alcohol Clin Exp Res 36:1021–1033. https://doi.org/10.1111/j.1530-0277.2011.01677.x
28. Wolfla CE, Ross RA, Crabb DW (1988) Induction of alcohol dehydrogenase activity and mRNA in hepatoma cells by dexamethasone. Archives of Biochemistry and Biophysics 263:69–76. https://doi.org/10.1016/0003-9861(88)90614-5
29. Alqahtani A, Khan Z, Alloghbi A, et al (2019) Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina (Kaunas) 55:E526. https://doi.org/10.3390/medicina55090526
30. Jiang H, Zhou Z, Jin S, et al (2018) PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Sci 109:1414–1427. https://doi.org/10.1111/cas.13598
31. Chen C-H, Ferreira JCB, Gross ER, Mochly-Rosen D (2014) Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities. Physiological Reviews 94:1–34. https://doi.org/10.1152/physrev.00017.2013
32. Chang B, Hao S, Zhang L, et al (2018) Association Between Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism and Alcoholic Liver Disease. The American Journal of the Medical Sciences 356:10–14. https://doi.org/10.1016/j.amjms.2018.03.012
33. Seitz HK, Stickel F (2010) Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr 5:121–128. https://doi.org/10.1007/s12263-009-0154-1
34. Costentin CE, Mourad A, Lahmek P, et al (2018) Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study: Delayed Diagnosis of Alcohol-Related HCC. Cancer 124:1964–1972. https://doi.org/10.1002/cncr.31215
35. Flores-Téllez TN, Villa-Treviño S, Piña-Vázquez C (2017) Road to stemness in hepatocellular carcinoma. WJG 23:6750–6776. https://doi.org/10.3748/wjg.v23.i37.6750
36. Bucci L, Garuti F, Camelli V, et al (2016) Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome. Aliment Pharmacol Ther 43:385–399. https://doi.org/10.1111/apt.13485
37. Freudenheim JL (2020) Alcohol�s Effects on Breast Cancer in Women. ARCR 40:arcr.v40.2.11. https://doi.org/10.35946/arcr.v40.2.11
38. Park NR, Cha JH, Jang JW, et al (2016) Synergistic effects of CD44 and TGF-b1 through AKT/GSK-3b/b-catenin signaling during epithelial-mesenchymal transition in liver cancer cells. Biochemical and Biophysical Research Communications 7
39. Liu Y-C, Yeh C-T, Lin K-H (2020) Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells 9:1331. https://doi.org/10.3390/cells9061331
40. Gu S, Nguyen B-N, Rao S, et al (2017) Alcohol, stem cells and cancer. Genes Cancer 8:695–700. https://doi.org/10.18632/genesandcancer.156
41. Rehm J (2020) Alcohol consumption. A leading risk factor for cancer. 8
42. Marron M, Boffetta P, Zhang Z-F, et al (2010) Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. International Journal of Epidemiology 39:182–196. https://doi.org/10.1093/ije/dyp291
43. Wood S, Pithadia R, Rehman T, et al (2013) Chronic Alcohol Exposure Renders Epithelial Cells Vulnerable to Bacterial Infection. PLoS ONE 8:e54646. https://doi.org/10.1371/journal.pone.0054646
44. Hamant C, Deneuve S, Albaret M-A, et al (2018) Accompagnement des dépendances à l’alcool et au tabac des patients atteints d’un cancer des voies aérodigestives supérieures. Bulletin du Cancer 105:1012–1019. https://doi.org/10.1016/j.bulcan.2018.07.006
45. Stoebner-Delbarre A, Gonzalez M-L, Gourlan M, Huteau M-E (2020) Le programme STAR : prise en charge addictologique théorico-clinique intégrée au parcours de soins en cancérologie. Psycho-Oncol 14:113–121. https://doi.org/10.3166/pson-2020-0129
46. Sanford NN, Sher DJ, Xu X, et al (2020) Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000–2017. Journal of the National Comprehensive Cancer Network 18:69–79. https://doi.org/10.6004/jnccn.2019.7341